0074-1055Level 3
EMRELIS (Telisotuzumab Vedotin)
**Product type:** Human Prescription Drug
**Active ingredient:** TELISOTUZUMAB VEDOTIN
**Strength:** 100 mg/mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** AbbVie Inc.
**Marketing category:** BLA (BLA761384)
GET
/api/v1/systems/ndc_fda/nodes/0074-1055Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.